- Home
- LSTA vs FTHM Comparison
LSTA vs FTHM Comparison
Compare LSTA & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LSTA | FTHM |
|---|---|---|
| Founded | 1980 | 2010 |
| Country | United States | United States |
| Employees | N/A | 270 |
| Industry | Misc Health and Biotechnology Services | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 36.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LSTA | FTHM |
|---|---|---|
| Price | $2.06 | $1.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $23.50 | $2.50 |
| AVG Volume (30 Days) | 22.1K | ★ 91.2K |
| Earning Date | 11-06-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,070,000.00 | ★ $421,612,000.00 |
| Revenue This Year | N/A | $30.07 |
| Revenue Next Year | N/A | $14.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 32.78 |
| 52 Week Low | $1.81 | $0.65 |
| 52 Week High | $4.20 | $3.37 |
Technical Indicators
Market Signals| Indicator | LSTA | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 48.84 | 41.77 |
| Support Level | $1.96 | $1.04 |
| Resistance Level | $2.10 | $1.17 |
| Average True Range (ATR) | 0.11 | 0.07 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 67.74 | 29.79 |
Price Performance
Historical ComparisonAbout LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.